[Comparative study of theoretical literature on cold pathogenic disease in Wai tai mi yao fang (Arcane Essentials from the Imperial Library) and Tai ping sheng hui fang (Taiping Holy Prescriptions for Universal Relief)].

In the Wai tai mi yao fang (Arcane Essentials from the Imperial Library) compiled in 752, its portion on cold pathogenic disorders embodies the achievements before the mid Tang Dynasty, whereas that in the Tai ping sheng hui fang (Taiping Holy Prescriptions for Universal Relief), compiled in 992 embodies those before the early Song Dynasty. Comparison on the theory of cold disorders in both books reveal that, during the 2 centuries period from mid Tang to early Song Dynasties, the texts as a carrier for the transmission of such theory in both show no distinct changes, but only with minor revisions and improvements.

Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations.

BACKGROUND: The incidence and clinical impact of coronavirus (CoV) infection in elderly persons and those with underlying cardiopulmonary disease over a long duration is not well described. We determined the incidence and clinical impact of 229E and OC43 CoV in this population during 4 consecutive winters, and compared illnesses to influenza A, respiratory syncytial virus, and human metapneumovirus. METHODS: CoV 229E and OC43 were detected by reverse transcription polymerase chain reaction and serology in 4 adult populations under surveillance for acute respiratory illness during the winters of 1999-2003. Cohorts included healthy young adults, healthy elderly adults, high-risk adults with underlying cardiopulmonary disease, and a hospitalized group. RESULTS: Three hundred ninety-eight CoV infections were identified, with annual infection rates ranging from 2.8% to 26% in prospective cohorts, and prevalence ranging from 3.3% to 11.1% in the hospitalized cohort. The incidence of infections with each strain was similar, although asymptomatic infection and viral coinfection was significantly more common with 229E than OC43 infection. Although the incidence and clinical manifestations were similar for each strain, OC43-infected subjects tended to seek more medical care, as OC43 was twice as common as 229E among the hospitalized cohort. CONCLUSIONS: CoV infections in the elderly are frequent, likely causing substantial medical disease burden.

[Franciszek Leopold Lafontaine (1756-1812) and his work on catarrh]. / Franciszek Leopold Lafontaine (1756-1812) i jego praca o katarze.

The professional and scientific activities of Leopold Lafontaine (1756-1812), an eminent military surgeon, the chief army surgeon in the Grand Duchy of Warsaw are presented in full particular. He was a editor-in-chief and publisher of the first Polish medical periodical "Dziennik Zdrowia dla Wszystkich Stanów" ("The Journal of Health for all the Estates"). His work on catarrh is discussed widely.

[Sinobronchitis--historical aspect]. / Zespól zatokowo-oskrzelowy w aspekcie historycznym.

There is evidence that a link exists between the upper and lower respiratory tracts. During the last fifty years many clinical observations has lead to a new pathogenic view of rhinosinusitis and asthma defined as Sinobronchial Syndrome. The inflammatory process in the nose and bronchi explains some of the complex interactions among different clinical diseases, such as rhinosinusitis, asthma, bronchial hyperresponsiveness and viral infections.

The St Kilda boat cough under the microscope.

The inhabitants of St Kilda, a remote archipelago in the Outer Hebrides, suffered from outbreaks of a respiratory tract infection known as the boat cough every time strangers visited their isolated community between the seventeenth and nineteenth centuries. This condition has always been labelled influenza, but a review of contemporary records and modern microbiological evidence strongly suggests the illness was due to rhinovirus.

Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council.

The 1948 report of the British Medical Research Council's randomized trial of streptomycin for pulmonary tuberculosis is widely regarded as marking the beginning of the modern history of controlled clinical trials. Four years earlier, however, a methodologically sophisticated multicentre trial conducted under the aegis of the Medical Research Council was reported, which assessed the effects of the antibiotic patulin on the course of common colds. Philip D'Arcy Hart and Joan Faulkner (later Joan Doll) were the secretary and assistant secretary, respectively, to the committee overseeing the trial, and they clearly recognized the importance of preventing foreknowledge of allocations from those admitting patients to the study. To do this and to 'muddle people up', they and Ruth D'Arcy Hart devised a scheme involving the use of two patulin groups and two placebo groups, allocating patients to one of these four groups using strict rotation. Philip D'Arcy Hart believes that this study has been overshadowed by the celebrated streptomycin trial (for which he was also secretary to the oversight committee) because no beneficial effect of patulin was detected, and because the report of the streptomycin trial referred to the use of random sampling numbers to generate the allocation schedule. This article makes clear why we agree with Philip D'Arcy Hart that the 1944 patulin trial deserves wider recognition as the first well controlled, multicentre clinical trial to have been conducted under the aegis of the British Medical Research Council. This status is reflected in the International Journal of Epidemiology's reproduction of the full text of the trial report in this issue of the journal.

[History of a plant: the example of Echinacea]. / Geschichte einer Pflanze am Beispiel von Echinacea.

In comparison with other medicinal plants, the history of use of Echinacea is relatively short. The plant originates from North America and was employed by the indigenous Indians. The first archaeological evidence dates from the 18th century. Included in the name Echinacea or purple coneflower are several species of the Asteraceae family: Echinacea purpurea (L.) Moench, Echinacea angustifolia DC. and Echinacea pallida (Nutt.) Nutt. Information about the use of the plant from traditional healers ranges from external application for wounds, burns and insect bites to the chewing of roots for toothache and throat infections, and internal application for pain, coughs, stomach cramps and snake bites. The interest of white settlers was also drawn to this medicinal plant. The first Echinacea preparation, known as Meyers Blood Purifier, arrived on the market around 1880, with rheumatism, neuralgia and rattlesnake bites as indications. At the beginning of the 20th century, Echinacea was the most frequently used plant preparation in the USA. Commercial cultivation was started in Germany around 1939. The introduction and cultivation of Echinacea in Switzerland by A. Vogel was around 1950. Chemists and pharmacologists became interested in Echinacea and many constituents are now known, such as polysaccharides, echinacoside, cichoric acid, ketoalkenes and alkylamides. The extracts exhibit immunostimulant properties and are mainly used in the prophylaxis and therapy of colds, flu and septic complaints. Although there are over 400 publications concerning the plant and dozens of preparations of Echinacea n the market, the true identity of the active principles still remains open.

Viral respiratory infection therapy: historical perspectives and current trials.

Attempts to relieve the misery of the common cold have been made since long before current understanding of its viral origin. Although current symptomatic therapies provide some relief, any effective treatment must incorporate an antiviral to address the infection. Symptom production is related not only to viral cytopathic effect but also to the early activation of several inflammatory pathways. Antiviral treatment alone may not be able to prevent these events. Combining an antiviral with selected therapeutic agents that block these inflammatory pathways has been shown to improve the effectiveness of cold treatment. Early diagnosis and initiation of treatment combined with regular dosing until symptoms subside appears to be the most effective treatment strategy to maximize therapeutic outcomes. This strategy reduces viral shedding in nasal fluid, provides treatment for the period of maximum symptom burden, and may reduce the frequency and severity of the sinus disease that accompanies colds.